Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | AMGN | BMY | GILD | VRTX |
| Company | Genmab A/S ADR | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 20.45 | 262.21 | 57.66 | 93.17 | 407.20 |
| High | 20.61 | 264.73 | 58.07 | 94.55 | 411.29 |
| Low | 20.41 | 261.76 | 57.51 | 92.97 | 406.02 |
| Last | 20.58 | 263.18 | 58.00 | 94.41 | 410.65 |
| Change | +0.11 | -1.31 | +0.24 | +0.46 | +2.47 |
| % Change | +0.54% | -0.50% | +0.42% | +0.49% | +0.61% |
| Volume | 751,703 | 1,636,912 | 4,688,582 | 2,915,355 | 1,191,491 |
| 20-Day Average Volume | 1,066,855 | 4,232,021 | 11,254,214 | 7,098,768 | 1,825,865 |
| Previous Close | 20.47 | 264.49 | 57.76 | 93.95 | 408.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 21.01 | 271.17 | 57.83 | 92.46 | 449.18 |
| 20-Day Raw Stochastic | 29.44% | 32.56% | 58.63% | 95.64% | 33.26% |
| 20-Day Relative Strength | 41.23% | 32.72% | 54.81% | 59.21% | 35.06% |
| Weighted Alpha | -37.30 | -15.18 | +21.20 | +26.94 | -7.12 |
| Today's Opinion | 100% Sell | 88% Sell | 96% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | 100% Sell | 72% Sell | 100% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.18% since 12/18/24 | +1.70% since 12/18/24 | +2.04% since 12/18/24 | +4.10% since 12/18/24 | -8.23% since 12/18/24 |
| Low | 19.99 on 12/19/24 | 253.30 on 12/19/24 | 56.08 on 12/20/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 20.85 on 12/23/24 | 269.61 on 12/20/24 | 58.07 on 12/26/24 | 94.55 on 12/26/24 | 411.29 on 12/26/24 |
| 1-Month | |||||
| %Chg | -0.34% since 11/26/24 | -6.01% since 11/26/24 | -1.26% since 11/26/24 | +3.35% since 11/26/24 | -12.08% since 11/26/24 |
| Low | 19.85 on 12/16/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 22.33 on 12/09/24 | 283.64 on 11/29/24 | 60.09 on 12/03/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -14.68% since 09/26/24 | -17.52% since 09/26/24 | +15.72% since 09/26/24 | +13.69% since 09/26/24 | -11.34% since 09/26/24 |
| Low | 19.85 on 12/16/24 | 253.30 on 12/19/24 | 50.71 on 09/27/24 | 82.82 on 10/01/24 | 377.85 on 12/19/24 |
| High | 24.43 on 09/27/24 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | -19.83% since 06/26/24 | -15.87% since 06/26/24 | +36.47% since 06/26/24 | +36.21% since 06/26/24 | -13.36% since 06/26/24 |
| Low | 19.85 on 12/16/24 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 28.56 on 07/31/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 13,546,390 | 142,172,096 | 117,147,504 | 117,086,688 | 105,118,176 |
| Shares Outstanding, K | 661,768 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 2,392,030,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 631,910,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 816,600,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | 186,610,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 0.96 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.29 on 11/06/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 02/12/25 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 20.16 | 13.74 | 49.21 | 21.08 | 0.00 |